Recommended Intramuscular Ceftriaxone Dose for Uncomplicated Gonorrhea
For uncomplicated gonorrhea in adults, administer ceftriaxone 500 mg IM as a single dose, regardless of anatomic site (urogenital, rectal, or pharyngeal). 1, 2, 3
Standard Adult Dosing
The FDA-approved labeling for Rocephin specifies 250 mg IM as a single dose for uncomplicated gonococcal infections 1. However, current CDC guidelines (2020/2021) have increased this to 500 mg IM based on antimicrobial stewardship principles and evolving resistance patterns 2, 3. This higher dose provides:
- Greater margin of safety against emerging resistance
- Consistent efficacy across all anatomic sites (including pharyngeal infections, which are harder to treat)
- Sustained bactericidal levels sufficient to overcome isolates with elevated MICs
The 2020 CDC update moved away from dual therapy with azithromycin due to rapidly rising azithromycin resistance (nearly 5% of isolates with elevated MICs by 2018), while ceftriaxone MICs have remained stable with <0.1% showing "alert values" 2, 3.
Chlamydia Coinfection Consideration
If chlamydial coinfection has not been excluded, add doxycycline 100 mg orally twice daily for 7 days 2, 3. This replaces the previous azithromycin dual therapy recommendation. Ceftriaxone has no activity against Chlamydia trachomatis 1.
Patients Weighing ≥150 kg
The evidence provided does not specify dose adjustments for patients weighing ≥150 kg. The FDA labeling states that no dosage adjustment is necessary for renal or hepatic impairment and that standard adult dosing applies to elderly patients up to 2 grams per day 1.
In the absence of specific guidance for high body weight, use the standard 500 mg IM dose, as:
- Ceftriaxone has a long half-life and excellent tissue penetration
- The total daily dose can safely reach 4 grams 1
- Clinical trials have not identified weight-based dosing requirements for uncomplicated infections
If treatment failure occurs in a patient with high body weight, this would warrant culture with susceptibility testing and consultation with infectious disease specialists 4.
Administration Technique
Inject well within the body of a relatively large muscle with aspiration to avoid intravascular injection 1. Reconstitute the 500 mg vial with 1.8 mL diluent to achieve 250 mg/mL concentration, or use 1 mL diluent for 350 mg/mL concentration 1.
Critical Caveats
- Avoid calcium-containing diluents (Ringer's solution, Hartmann's solution) due to precipitation risk 1
- Contraindicated in neonates ≤28 days requiring calcium-containing IV solutions 1
- Report suspected treatment failures to local health departments within 24 hours and obtain cultures with susceptibility testing 4
- Limited alternatives exist for cephalosporin-allergic patients, particularly for pharyngeal infections 2, 5
Treatment Failure Management
If treatment failure occurs (rare with current regimens), European guidelines recommend ceftriaxone 1 g IM plus azithromycin 2 g orally, while CDC recommends gentamicin 240 mg IM plus azithromycin 2 g orally after obtaining cultures 4. However, both gentamicin and spectinomycin have poor pharyngeal efficacy (only 2 of 10 pharyngeal cases cured with gentamicin in one study) 4.